Cancer Research Technology
Log in Register
Menu

Anti-ASAP1 [7B12]

Invented at Karlsruhe Institute of Technology

Info

Catalogue Number 151767
Applications ELISA IHC IP WB
Antigen/Gene or Protein Targets ASAP1
Reactivity Human and Rat
Relevance ASAP1 possesses phosphatidylinositol 4,5-biphosphate-dependent GTPase-activating protein activity for ARF1 (ADP ribosylation factor 1) and ARF5 and a lesser activity towards ARF6. It may coordinate membrane trafficking with cell growth or actin cytoskeleton remodeling by binding to both SRC and PIP2. It potentially has involvement in tumour progression, having been shown to promote metastasis formation in vivo and stimulate tumor cell motility, invasiveness, and adhesiveness in vitro. ASAP1 represents a potential target for cancer therapy.
Host Mouse
Immunogen Recombinant Protein (fragment of human ASAP1 (corresponding nucleotides 977-1532 of KIAA1249) with N-terminal GST tag produced in E.coli strain BL-21)
Positive Control Human: HT29 and MDA-MB-231 Rat: ASAP1 is strongly expressed in ASML and weakly expressed in 1AS pancreatic carcinoma cells.
Subclass IgG2b
Myeloma Used Sp2/0-Ag14
Recommended Growing Conditions 10% FCS + RPMI + Pen/Strep
Notes Other research areas applicable: Metastasis, cytoskeleton, vesicle trafficking.

WB WB: Use a concentration of 1 µg/ml. Predicted molecular weight: 125 kDa.

IHC-P IHC-P: Use a concentration of 5 µg/ml.

IHC-Fr IHC-Fr: Use a concentration of 5 µg/ml.

IP IP: Use a concentration of 10 µg/ml.

ELISA ELISA: Use at an assay dependent concentration.
Research Area Cancer, Cell Type or Organelle Marker, Cell Signaling & Signal Transduction

References

There are 2 reference entries for this reagent.

View All References

References: 2 entries

Müller et al. 2010. Oncogene. 29(16):2393-403. PMID: 20154719.

WB IHC

ASAP1 promotes tumor cell motility and invasiveness, stimulates metastasis formation in vivo, and correlates with poor survival in colorectal cancer patients.

Europe PMC ID: 20154719


Add a reference

References: 2 entries

Müller et al. 2010. Oncogene. 29(16):2393-403. PMID: 20154719.

WB IHC

ASAP1 promotes tumor cell motility and invasiveness, stimulates metastasis formation in vivo, and correlates with poor survival in colorectal cancer patients.


Add a reference

Inventor Information

No inventors are currently linked to this reagent.

Add an inventor